Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lim, Sue, Bast, Darrin, McGeer, Allison, de Azavedo, Joyce, Low, Donald E.
Formato: Artigo
Idioma:Inglês
Publicado: Centers for Disease Control and Prevention 2003
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3023429/
https://ncbi.nlm.nih.gov/pubmed/12890324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0907.020589
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares